News Features Year in Review: SGLT2 Inhibition, Lipid-Lowering Make Waves in Clinical Cardiology in 2019 Todd Neale December 10, 2019
News Conference News AHA 2019 AHA 2019: Beyond ISCHEMIA Are Plenty of Coronary, Structural, and HF Trials Shelley Wood November 11, 2019
News Conference News TCT 2019 Leave It Be: PCI for Stable CAD Before or With TAVR Does Not Lower Mortality Risk Michael O'Riordan September 29, 2019
News Opinion Editor's Corner TCT 2019 TCT 2019 Day Three: Thowback Saturday Revisits COAPT, PARTNER 2A, and EXCEL Shelley Wood September 28, 2019
News Conference News TCT 2019 TCT 2019: Pharmacotherapy in PCI, Head-to-Head Valves, YouTube Rappers, and More Shelley Wood September 19, 2019
News Conference News ESC 2019 ESC 2019: Antiplatelets in Diabetes, CAD and A-fib, an ARNI in HFpEF, Staged Complete PCI, and More Shelley Wood August 22, 2019
News Daily News No Volume-Outcome Link With Watchman for LAA Closure? Single-Center Study Michael O'Riordan August 19, 2019
News Industry News Neovasc Provides Further Update on Reducer™ Program for Treatment of Refractory Angina July 16, 2019
News Conference News TVT 2019 PCI During or After TAVR No Riskier Than PCI Before Valve Replacement Michael O'Riordan June 13, 2019
News Industry News Cordis Continues to Expand Interventional Cardiology Portfolio with Radial Offering May 14, 2019
News Industry News Neovasc Announces Treatment of 1,000th Refractory Angina Patient with Neovasc Reducer™ May 06, 2019
News Industry News Neovasc Announces Peer Reviewed Publication in the International Journal of Cardiology Demonstrating that the Neovasc Reducer™ Improves Diastolic Function in patients suffering from severe angina April 17, 2019
Presentation ARCH 2019 A Glimpse at Boston Scientific’s Structural Heart Therapies PortfolioAdvanced Revascularization Chapter XII Presenter: David G. Rizik April 11, 2019
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for December 2018 Caitlin E. Cox January 01, 2019